Introduction
With a size of about 100 to 10000 times smaller than human cells, nanoparticles offer unprecedented potentials to interact with biomolecules and to revolutionize disease diagnosis and treatment. As an example, nanoparticles have recently attracted significant attention as the vehicle to deliver and release drugs and therapeutic agents to the disease site [9, 28] to achieve highly localized therapeutic strategies. Such localized therapeutic applications ultimately necessitate a targeted intracellular delivery and availability of the nanoparticles to specific target cells [7, 9, 28] . The interaction between nanoparticles and target cells often includes two steps: delivery and accumulation. During the delivery step, the nanoparticles (administrated through the blood stream or directly injected to the site of interest) are delivered to the vicinity of target cells via different mechanism such as enhanced permeability and retention (EPR) effect [36] . Second, the delivered nanoparticles accumulate within the target cells through endocytosis, which is one of the primary membrane translocation mechanisms for nanoparticles entry into the living cells [15] . Fully understanding the interactions between nanoparticles and cells is an enormous advancement towards evaluating the utility of molecularly targeted nanoparticles in both diagnostic and therapeutic applications. In an ideal scenario, nanoparticles which are utilized as biosensors must be activated or generate signal only when they have entered the cells through endocytosis. However, in real applications, signals are generated not only from the endocytosed nanoparticles but also from the nanoparticles in the vicinity of the cells; and it is extremely difficult to differentiate between these signals. Most molecular imaging modalities have limited sensitivity and resolution to specifically sense the endocytosis of nanoparticles into living cells mostly due to similar signature of the obscuring signal generated by the delivered yet not endocytosed nanoparticles [4, 43] . Therefore, imaging strategies capable of detecting nanoparticle delivery and sensing of their intracellular endocytosis is highly desirable.
Magneto-photo-acoustic (MPA) imaging was developed based on the integration of ultrasound (US) [6] , photoacoustic (PA) [3, 13, 27, 39, 41] , and magneto-motive ultrasound (MMUS) [18] [19] [20] [21] [22] 26] imaging modalities [11, [31] [32] [33] 35] . By utilizing magnetoplasmonic nanoparticles as imaging contrast agent, MPA can provide imaging information at cellular and molecular level with a high resolution and sensitivity [10, 33] . In our previous studies, we Many biomedical applications necessitate a targeted intracellular delivery of the nanomaterial to specific cells. Therefore, a non-invasive and reliable imaging tool is required to detect both the delivery and cellular endocytosis of the nanoparticles. Herein, we demonstrate that magneto-photo-acoustic (MPA) imaging can be used to monitor the delivery and to identify endocytosis of magnetic and optically absorbing nanoparticles. The relationship between photoacoustic (PA) and magneto-motive ultrasound (MMUS) signals from the in vitro samples were analyzed to identify the delivery and endocytosis of nanoparticles. The results indicated that during the delivery of nanoparticles to the vicinity of the cells, both PA and MMUS signals are almost linearly proportional. However, accumulation of nanoparticles within the cells leads to nonlinear MMUS-PA relationship, due to non-linear MMUS signal amplification. Therefore, through longitudinal MPA imaging, it is possible to monitor the delivery of nanoparticles and identify the endocytosis of the nanoparticles by living cells. have reported a phenomenon that the intracellular accumulation of magnetic nanoparticles generates larger MMUS signals than the same concentration of isolated nanoparticles [22, 23] . Furthermore, we demonstrated that MPA imaging could differentiate between the isolated nanoparticles in the vicinity of the cells and the accumulated nanoparticles within the cells [34] . In MPA imaging, the amplitude of the PA signal is proportional to the concentration of optical absorbers, i.e. magneto-plasmonic nanoparticles. Although accumulation of plasmonic metallic nanoparticles could increase the local heating effect and thus introduces linear and even nonlinear amplification of PA signal in aggregated and accumulated nanoparticles [25] , such phenomenon may not happen for some types of nanoparticles such as dye-doped silica-coated magnetic particles [1, 24] . On the other hand, when such nanoparticles are endocytosed, confined in lysosomes, and form intracellular aggregates with much larger size than isolated nanoparticles [5, 8, 12, 38] , the MMUS signal is amplified significantly. In other words, the MMUS signal from nanoparticles depends on both the concentration of nanoparticles and their functional state (i.e., isolated or endocytosed/aggregated) [22, 23] . Therefore, the ratio between MMUS and PA (MMUS/PA) signals represents the magnetically induced motion from the unit concentration of nanoparticles. Such ratio, monitored over time, could identify both the delivery of nanoparticles and endocytosis of nanoparticles by cells. Our previous work provided an initial framework for noninvasive detection of endocytosis of nanoparticles using MPA imaging [34] . In the current study, we further evaluate the utility of MPA imaging, coupled with an analytical method, to monitor nanoparticle delivery and to detect the endocytosis process. Herein, we propose a longitudinal analysis of MPA signal to monitor accumulation and endocytosis of nanoparticles within the cells. To achieve this goal, cell-tissue mimicking phantoms were designed to closely mimic the realistic in vivo scenario, in which some of the nanoparticles were endocytosed by the cells of interest, while the rest of the isolated nanoparticles were present in the vicinity of the cells. Two in vitro sets of experiments were designed to simulate the delivery and endocytosis of nanoparticles. The MPA imaging experiments were performed and the relationship between PA and MMUS signals were analyzed to identify the delivery and cellular accumulation processes.
Materials and Methods

Synthesis of magnetic nanoparticles as MPA contrast agents
Citrate-capped magnetite (Fe 3 O 4 ) nanoparticles with optical absorption at the visible wavelength and large magnetic susceptibility (56 emu/gr Fe) were used as contrast agent in our MPA imaging studies. The citrate-capped Fe 3 O 4 nanoparticles were synthesized through a phase transfer reaction between tri(ethylene glycol)-coated Fe 3 O 4 nanoparticles in ethanol and an aqueous solution of 14 mg/mL sodium citrate (Sigma-Aldrich) in nano-pure water [33, 37] . The volume ratio between the tri(ethylene glycol)-coated Fe 3 (Fig. 1A) . As shown previously, the Fe 3 O 4 nanoparticles possessed strong optical absorption in visible wavelengths and high magnetic susceptibility [33] . In this study, the synthesized SPIO nanoparticles does not show plasmonic effect that can potentially interfere with hypothesis behind this study. These contrast agents do not have absorption peak within near infrared (NIR) region and absorb relatively high at 532 nm. Therefore, PA imaging experiments were performed at 532 nm wavelength.
Cell-nanoparticles tissue mimicking phantoms
The macrophages (J774 A1) cells were incubated with citratecapped Fe 3 O 4 nanoparticles for 24 hours. Then the harvested macrophages were washed three times with phosphate buffered saline (PBS). Cellular uptake, measured using inductively coupled plasma mass spectrometry (ICP-MS), was approximately 6.7 Â 10 6 citrate-capped Fe 3 O 4 nanoparticles (7.65 pg Fe 3 O 4 nanoparticles) per cell. The TEM image of macrophages with endocytosed nanoparticles is shown in Fig. 1(B) . Two tissue-mimicking gelatin phantoms were prepared to simulate the delivery and endocytosis processes of nanoparticles (Fig. 2) . The background of the tissue-mimicking phantoms was made out of 3 wt/wt gelatin (300 bloom, Sigma Aldrich, MO, USA). The inclusions were prepared by mixing 3 wt/wt gelatins with Fe 3 O 4 nanoparticles at different concentrations or functional states (i.e., endocytosed Fe 3 O 4 nanoparticles, isolated nanoparticles, or mixture of both). In the first phantom, inclusions I to V contained non-labeled cells mixed with different concentrations of isolated Fe 3 O 4 nanoparticles, mimicking NP delivery into tissues. Inclusion I contained macrophage cells only and served as control; the remaining inclusions contained 0.2 mg/mL (inclusion II), 0.4 mg/ mL (inclusion III), 0.67 mg/mL (inclusion IV), and 1 mg/mL (inclusion V) Fe 3 O 4 nanoparticles mixed with cells.
The second phantom was made to simulate the endocytosis process. The endocytosis process can be considered as a two-stage process. In the first stage, the nanoparticles are delivered to the vicinity of cells and then in second stage, they are endocytosed by the cells. To simulate this process, two set of cells were prepared: (a) cells loaded with nanoparticles, and (b) intact (unloaded) cells. Knowing the average number of nanoparticles in loaded cells (through ICP-MS measurements), four inclusions were made out of gelatin and mixture of nanoparticles and magnetically labeled cells. While the concentration of magnetite nanoparticles was kept the same in all four inclusions, the ratio between the endocytosed nanoparticles (contained in labeled cells) and the isolated nanoparticles was different. For example, in phantom VI, 25% of total nanoparticles were within the loaded cells, and the rest were simply mixed with intact cells. Therefore, inclusions XI to IX have the same number or concentration of nanoparticles as well as the same number of cells. However, the portion of nanoparticles within the cells and mixed with the cells were changed. The different ratios mimicked the cellular uptake of nanoparticles by living cells in vivo. The parameter E in Fig. 2(B) 
The total number of Fe 3 O 4 nanoparticles within the inclusions include both endocytosed nanoparticles inside cells and isolated nanoparticles in the vicinity of cells. The increase of E indicates the larger uptake of nanoparticles by the macrophage cells. Parameter E was precisely controlled and varied between 25% to 100% with an increment of 25%. As a result, inclusions VI, VII, VIII, and IX contain 25%, 50%, 75%, and 100% of nanoparticles in endocytosed functional state. To eliminate any experimental dependent variation in MPA measurements, an identical number of macrophage cells (3.75 Â 10 6 cells) was embedded in all inclusions. In addition, 0.2 wt% of 30 mm silica particles, acting as ultrasound scatters, was added to the inclusions.
MPA imaging
To evaluate the ability of MPA imaging to assess nanoparticles endocytosis process, MPA imaging system shown in Fig. 3 was used to image tissue-mimicking phantoms. Samples were placed in a water cuvette that was attached to a 3D positioning stage. The laser Second phantom was designed to mimic endocytosis of nanoparticles. Parameter E represented the endocytosis ratio, which was defined as the ratio of the number of endocytosed nanoparticles to the total number of nanoparticles in tissue (both endocytosed nanoparticles and isolated nanoparticles in the vicinity of cells). Inclusions VI to IX mimicked different portions of nanoparticles were endocytosed by living cells. Fig. 3 . Magneto-photo-acoustic (MPA) imaging system block diagram including ultrasound pulser/receiver, laser and magnetic excitation.
source was a tunable optical parametric oscillator (OPO, SpectraPhysics) laser system (400$2600 nm wavelength range, 5$7 ns pulse duration, up to 10 Hz pulse repetition frequency). The pulsed laser light at 532 nm wavelength was delivered to the samples through a 1500 mm diameter optical fiber. The fluence of the laser was measured as 10 mJ/cm 2 with power meter (Nova II, Ophir Ltd., Jerusalem, Israel). A single-element focused US transducer (25 MHz center frequency, bandwidths of about 50%, 25.4 mm focal depth, f-number of 4, Olympus-NDT, Waltham, MA, USA) was used for pulse-echo US imaging as well as for PA signal detection. The imaging sequence was set as following. First, the PA signal is generated and detected by the US transduce. After a delay of 30 ms, US pulse was sent to the sample and the backscattered US echo signal was detected to form US image. Then a pulsed magnetic field with 20 ms pulse duration was applied from the bottom of the sample through a solenoid with a cone-shaped-tip core to focus the field to induce the magneto-motive displacement. The magnetic flux density (B) was measured as 0.8 T at the tip of a cone shaped core embedded within the coil by using a digital Gaussmeter (DSP 475, Lakeshore Crytronics, OH, USA). The air gap between the water tank and iron core tip was about 1 mm to avoid any direct contact between the sample and magnetic field generator. The US pulse-echo signals were acquired to track the magnetically induced displacement from the sample. The repetition rate of the US pulses sent to the sample was 1 kHz. A total of 100 pulseechoes (100 ms) were acquired for the displacement tracking, in which 20 pulse-echoes (20 ms) were measured before the application of the magnetic field and used as the static reference of motion detection. After the magnetic excitation, 80 pulse-echo signals over 80 ms time interval were acquired to track the magnetically induced. At each data point, the temporal behavior of the displacement was calculated by estimating the cross-correlation between the static signal and the signals acquired after the magnetic field application [17] . The maximum measured displacement was used to form MMUS image. A custom-built LabVIEW (National Instruments, TX, USA) application was used to control the mechanical scanning to provide spatially co-registered US, PA and MMUS images. The US, PA and MMUS images of inclusions within each tissuemimicking phantom were reconstructed and spatially co-registered. To further analyze the ability of MPA imaging to detect the delivery of nanoparticles and endocytosis, the regions of interest of the same size were selected within each inclusion. The amplitude of PA and MMUS signal was averaged within each region of interest. Then the PA signal was plotted versus MMUS signal for each inclusions, and the realationship between both signals was studied. Specifically, based on the linear fitting, the slopes of PA-MMUS curves for the inclusions within phantoms were compared to indicate the processes of delivery and celluar endocytosis.
Results and Discussion
The US images of the first phantom, which mimicked the delivery of nanoparticles to the vicinity of cells, are shown in Fig. 4(A) . The averaged amplitude of the PA signal from each inclusion (marked with yellow semicircle) is displayed in Fig. 4B . The error bars in Fig. 4B show the standard deviation of the PA signal magnitude from multiple measurements. There was no significant PA signal detected from inclusion I, which did not contain any Fe 3 O 4 nanoparticles and was used as a control. The PA signals from inclusions II to V indicate that the amplitude of PA signals increased proportional to the concentration of nanoparticles. This result is consistent with the linear dependence of PA signals on the concentration of nanoparticles (gold nanorods) shown in previous studies [34] . The magnetically induced displacement was measured from the regions outlined with red rectangle (1000 mm axially and 500 mm laterally) in each inclusion. The mean and standard deviation of MMUS signal from each inclusion are displayed in Fig. 4C . As the concentration of nanoparticles increases, the magnetically induced displacement increases. Finally, the relationship between PA and MMUS signals is shown in Fig. 4D . In Fig. 4D , the PA signal amplitude is shown in vertical axis, while the amplitude of MMUS signal is shown in horizontal axis. The fitting curve of PA-MMUS plot indicates the linear relationship between PA and MMUS signals for the isolated nanoparticles. In other words, when the nanoparticles are delivered into the tissue, both PA and MMUS signal showed a monotonic increase with respect to the concentration of nanoparticles. Therefore, a positive slope of PA-MMUS curve was associated with the delivery process.
The US images of the inclusions in second phantom, which mimicked the endocytosis of nanoparticles by the living cells, are shown in Fig. 5(A) . Four inclusions contained the same concentration of Fe 3 O 4 nanoparticles (0.67 mg/mL) with different endocytosis ratio E. The E value for inclusions VI, VII, VIII, and IX was 25%, 50%, 75%, and 100%, respectively. Similar to the previous phantom, PA and MMUS signals, as well as their ratio for different inclusions, were measured and analyzed (Fig. 5B-D) . PA signals from all the inclusions were approximately the same, which was expected given the same concentration of nanoparticles in all inclusions [34]. On the other hand, the MMUS signal (i.e. magnetically induced displacement) increased significantly when E value was larger, indicating more nanoparticles entered into cells. Thus MMUS signal was sensitive to the endocytosis process (Fig. 5C ). Finally the relationship between PA and MMUS signals (Fig. 5D) shows a different trend compared to the delivery process. As more Fe 3 O 4 nanoparticles were endocytosed, the PA signal remained constant while the MMUS signal increased. Therefore, the slope of the PA -MMUS curve was zero during the endocytosis process.
The results shown in Figures 4 and 5 suggest that MPA imaging is capable of monitoring the delivery and intracellular endocytosis of nanoparticles. During the nanoparticles' delivery, the concentration of nanoparticles increases, and both PA and MMUS signals increase linearly. Thus a linear relationship between PA and MMUS signals was observed (Fig. 4D) . In the process of nanoparticles' endocytosis, assuming the concentration of nanoparticles remains constant, PA signal is relatively constant, while the MMUS signal is amplified due to the aggregation of endocytosed nanoparticles within the endosomes [5, 8, 12, 22, 34, 38] . Thus the slope of PA-MMUS curve is zero for endocytosis process. Therefore, nanoparticles' delivery and endocytosis can be detected by investigating the relationship between PA and MMUS signals. Such ability of MPA imaging could be advantageous for several biomedical applications of nanoparticles such as drug delivery [14] , cancer therapy [29] , biosensors [16] .
From above results, at the same concentration of nanoparticles, the amplitude of MMUS signal is directly related to the ratio of endocytosed nanoparticles. In MMUS imaging, the magnetomotive force (F) acting on a magnetic NP that causing the displacement can be expressed as
where V np is the total size of the NP, f m is a dimensionless factor that represents the volumetric ratio of magnetic material in a NP, z is the direction along the magnetic field, m 0 is vacuum permeability, B z is magnetic flux density, and x np is the volume magnetic susceptibility of the NP. From Equation (1), the induced MMUS signal is proportional to the magnetic susceptibility of the NPs. For dilute solution of magnetic particles, the magnetic susceptibility is proportional to particle concentration [2] However, as particle concentration increases, the magnetic susceptibility increases faster than linear dependence due to the interaction between the particles [30] . Especially, when aggregates were formed, a significant non-linear amplification was observed in magnetic susceptibility, resulting in larger MMUS signals [22] . MMUS imaging is sensitive to detect aggregations containing several Fe 3 O 4 NPs [22] . When nanoparticles were endocytosed by the cells, the aggregates, formed within lysosomal bodies, contain several to tens of nanoparticles [5, 8, 12, 38] (Fig. 1) . The interaction between the Fe 3 O 4 NPs in the aggregate resulted in larger susceptibility and increased MMUS signals. Therefore, the larger magnetically induced displacement from the endocytosed NPs compared to that from the same concentration of isolated NPs is due to the interaction between magnetic NPs.
Longitudinal MPA imaging has the potential to monitor the delivery and endocytosis of nanoparticles in vivo. When nanoparticles are injected locally or systemically, they will accumulate in the site of interest and be present in the vicinity of the cells at first, Then the NPs will be endocytosed by the cells and form aggregates in membrane vesicles. The analysis of PA-MMUS curve over time is indicative of each stage of the process. When the nanoparticles start accumulating, the PA-MMUS curve would exhibit a positive slope, considering the dependence of both PA and MMUS signals on the concentration of nanoparticles. When certain amount of nanoparticles is accumulated, some of them enter into the cells through endocytic process, and the MMUS signal would increase nonlinearly. Thus, the slope of PA-MMUS will reduce. Finally, when a delivery equilibrium is achieved, the concentration of nanparticles in the region of interest will not change while more nanoparticles will be endocytosed by the cells. In tis case, the PA signal will be constant, while the MMUS signal will keep increasing due to stronger MMUS response from the endocytosed nanoparticles. Thus the PA-MMUS curve will have a zero slope for this stage. Therefore, without a prior information, longitunal MPA imaging along should be able to monitor the delivery and endocytosis processes non-invasively in vivo.
In the current in vitro study, Fe 3 O 4 nanoparticles were used as contrast agent for both PA and MMUS imaging, given their biocompatibility and availability, to investigate the interaction between nanoparticles with macrophage cells. For further advanced applications, magneto-plasmonic nanoconstructs could be used as contrast agents for the MPA imaging [40, 42] . Coupling with the capability of MPA imaging to sense endocytosed nanoparticles, the dual-contrast nanoparticles could be used as biosensors in living cells. 
Conclusions
In conclusion, this study demonstrated that the delivery and cellular endocytosis of nanoparticles can be noninvasively sensed by MPA imaging. In MPA imaging, the relationship between PA and MMUS signals was analyzed to be indicative of the functional processes of nanoparticles in tissue. When the nanoparticles were delivered into tissue, both PA and MMUS signals increased linearly to the NP concentration. On the other hand, when the nanoparticles entered into living cells based on endocytosis, the PA signal remained relatively constant while the MMUS signal was amplified. Therefore, the slope of MMUS-PA curve can provide information on the delivery and endocytosis processes of the nanoparticles.
